Form 4 for ALLO Allogene Therapeutics, Inc.

Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-07 · accession 0001214659-22-003836 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2022-03-09	2022-03-07	ALLO	Kazam Joshua A	Dir	J - Other	$0.00	+412.6K	671.5K	+159%	$0
	2022-03-09	2022-03-07	ALLO	Kazam Joshua A	Dir	G - Gift	$0.00	-412.6K	258.9K	-61%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-07	J	A	412,618	$0.00	671,503	D	—	—	(F1) The transactions reported in this form did not involve a purchase or sale of securities by the reporting person. On March 7, 2022, the reporting person acquired securities previously held in trust for the benefit of the reporting person arising from the termination of the trust. On the same day, the reporting person transferred the same securities to an irrevocable grantor trust having an independent trustee. The reporting person disclaims beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein.
2	Common	Common Stock	2022-03-07	G	D	412,618	$0.00	258,885	D	—	—	(F1) The transactions reported in this form did not involve a purchase or sale of securities by the reporting person. On March 7, 2022, the reporting person acquired securities previously held in trust for the benefit of the reporting person arising from the termination of the trust. On the same day, the reporting person transferred the same securities to an irrevocable grantor trust having an independent trustee. The reporting person disclaims beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein.